Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
Thermo Scientific ChromaCare flush solutions and Thermo Scientific UHPLC-MS solvents intend to help prevent protein precipitation for high-quality chromatograms
Experts find that the painkiller blocks a key process linked to tumor formation
Copley Scientific unveils new products to investigate the impact of facemasks when used in place of a mouthpiece
Learn how the use of covalent compounds within the pharmaceutical industry can improve drug discovery
Complete and easy-to-use LC-MS-based solution for biotherapeutics characterization and quality testing
RedShiftBio launches new AQS3pro System for protein characterization
Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs
The novel insect protein expression system promises superior protein yields, consistent results, a streamlined workflow and scales from discovery to production
AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics
The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics
The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Exciting new discovery describes the mechanism of action of a new class of antibiotics
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis
